Marijuana Legalization in Canada: 4 Stocks That Could Reach New Highs

Is commercial marijuana legislation all about protecting the youth, or does Canada want a new taxation revenue stream?

SmallCapPower | April 22, 2016: Canada’s pending marijuana legalization bill will surely flock new industry participants into the space, as well as current medical marijuana growers to consider expansion into recreational production. Included in our list today are four marijuana-related stocks we think will do well because of this.

Canopy Growth Corp. (CVE:CGC) – $2.79
Pharmaceuticals

Canopy Growth Corp, formerly Tweed Marijuana Inc., is a Canada-based producer of medical marijuana. The Company, through its subsidiaries, Tweed Inc., Tweed Farms Inc. and Bedrocan Cannabis Inc. is engaged in the business of producing and selling medical marijuana in Canada. Canopy also offers cannabis oils to practitioners and patients.

The company is reporting on the 26th, with a mean EPS estimate of $0.56, a 32% drop from a year ago.

• Market Cap: $1,790,728,391
• Revenue (LTM): $6,043,300
• Total Assets: $149,546,000
• YTD Price Change: -6%

Aurora Cannabis Inc. (CNSX:ACB) – $0.56
Fishing & Farming

Aurora Cannabis Inc (Aurora) is a Canada-based company operating via its subsidiary, Aurora Cannabis Enterprises Inc, as a licensed producer of medical marihuana pursuant to the Marihuana for Medical Purposes Regulations. It operates an approximately 55 thousand square foot expandable production facility in Alberta, Canada.

The company is reporting on the 20th, with a mean EPS estimate of $0.67, a 47% rise from a year ago.

• Market Cap: $63,836,895
• Revenue (LTM): $0
• Total Assets: $16,760,840
• YTD Price Change: 0%

Mettrum Health Corp. (CVE:MT) – $1.60
Pharmaceuticals

Mettrum Health Corp. (Mettrum), formerly Cinaport Acquisition Corp., is a Canada-based agri-pharmaceutical company. The Company, through its wholly-owned subsidiary, Mettrum Ltd., is engaged in the research, development, production and distribution of cannabis products to the Canadian market. The Company also owns a 100% interest in Oilseed Works Inc. (OWI), which operates under the Hempola brand and is a Health Canada licensed producer and processor of cannabis-based products.

The company is reporting on the 15th, with a mean EPS estimate of $1.03, a 32% drop from a year ago.

• Market Cap: $54,436,153
• Revenue (LTM): $5,824,790
• Total Assets: $36,254,480
• YTD Price Change: -15%

Supreme Pharmaceuticals Inc. (CNSX:SL) – $0.375
Pharmaceuticals

Supreme Pharmaceuticals Inc. (Supreme), formerly, Supreme Resources Ltd, is a Canada-based development company focusing on medical marijuana industry. The principal activities of Supreme are the production and sale of medical marijuana as regulated by Marihuana for Medical Purposes Regulations.

The company is reporting on the 17th, with a mean EPS estimate of $0.46, a 62% drop from a year ago.

• Market Cap: $40,288,607
• Revenue (LTM): $0
• Total Assets: $19,810,220
• YTD Price Change: -26%

Win Big With Our Small Cap Picks

Leave this field empty if you're human:

DISCLAIMER
The Content contained on this page (including any facts, views, opinions, recommendations, description of, or references to, products or securities) made available by SmallCapPower/Ubika Research is for information purposes only and is not tailored to the needs or circumstances of any particular person. Any mention of a particular security is merely a general discussion of the merits and risks associated there with and is not to be used or construed as an offer to sell, a solicitation of an offer to buy, or an endorsement, recommendation, or sponsorship of any entity or security by SmallCapPower/Ubika Research. The Reader should apply his/her own judgment in making any use of any Content, including, without limitation, the use of any information contained therein as the basis for any conclusions. The Reader bears responsibility for his/her own investment research and decisions. Before making any investment decision, it is strongly recommended that you seek outside advice from a qualified investment advisor. SmallCapPower/Ubika Research does not provide or guarantee any financial, legal, tax, or accounting advice or advice regarding the suitability, profitability, or potential value of any particular investment, security, or information source.